• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症中的食管受累及肺部表现

Esophageal involvement and pulmonary manifestations in systemic sclerosis.

作者信息

Marie I, Dominique S, Levesque H, Ducrotté P, Denis P, Hellot M F, Courtois H

机构信息

Department of Internal Medicine, Centre Hospitalier Universitaire de Rouen-Boisguillaume, France.

出版信息

Arthritis Rheum. 2001 Aug;45(4):346-54. doi: 10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L.

DOI:10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L
PMID:11501722
Abstract

OBJECTIVE

To assess whether esophageal manometric motor disturbances are associated with abnormalities consistent with interstitial lung disease (ILD) on both pulmonary function tests (PFT) and high resolution computerized tomography (HRCT) scans in patients with systemic sclerosis (SSc), during initial evaluation and at 2 years followup.

METHODS

Esophageal manometry, PFT, and HRCT scans were performed in 43 consecutive SSc patients. PFT and HRCT scan parameters were compared between patients with severe esophageal motor dysfunction (i.e., aperistalsis and decreased low esophageal sphincter pressure), patients with moderate esophageal motor dysfunction (hypoperistalsis), and patients without esophageal motor dysfunction on manometry.

RESULTS

During initial evaluation of SSc, patients with severe esophageal motor impairment, compared with those with moderate and without esophageal dysmotility, exhibited significantly decreased median values of diffusing capacity for carbon monoxide (DLco) (68% vs. 94% vs. 104%) and exhibited higher prevalence of evidence for ILD on HRCT scan (57% vs. 27% vs. 18%). At 2 years followup of SSc, patients with severe esophageal motor disturbances, compared with those without, had faster deterioration of DLco median values (-16% vs. +1%) and higher frequency of ILD on HRCT scan (70% vs. 25%).

CONCLUSION

Our series underscores a correlation between the degree of esophageal manometric motor disturbances and evidence for ILD on PFT and HRCT scan in SSc patients, suggesting that gastroesophageal reflux (GER) may be one of the contributing factors of ILD in SSc. Our findings further indicate that patients with severe esophageal impairment may require closer followup of lung parameters. In turn, it suggests that aggressive therapy of GER should be initiated in these SSc patients, as it may result in decreased deterioration of pulmonary function.

摘要

目的

评估在系统性硬化症(SSc)患者的初始评估及2年随访期间,食管测压运动障碍是否与肺功能测试(PFT)及高分辨率计算机断层扫描(HRCT)扫描中符合间质性肺病(ILD)的异常情况相关。

方法

对43例连续的SSc患者进行食管测压、PFT及HRCT扫描。比较食管运动功能严重障碍(即无蠕动及食管下括约肌压力降低)患者、食管运动功能中度障碍(蠕动减弱)患者及测压时无食管运动功能障碍患者的PFT和HRCT扫描参数。

结果

在SSc的初始评估中,与中度及无食管运动障碍的患者相比,食管运动功能严重受损的患者一氧化碳弥散量(DLco)的中位数显著降低(分别为68%、94%和104%),且HRCT扫描显示ILD的患病率更高(分别为57%、27%和18%)。在SSc患者2年随访时,与无食管运动障碍的患者相比,食管运动功能严重障碍的患者DLco中位数的恶化速度更快(分别为-16%和+1%),HRCT扫描显示ILD的频率更高(分别为70%和25%)。

结论

我们的系列研究强调了SSc患者食管测压运动障碍程度与PFT及HRCT扫描中ILD证据之间的相关性,提示胃食管反流(GER)可能是SSc中ILD的促成因素之一。我们的研究结果进一步表明,食管严重受损的患者可能需要更密切地随访肺部参数。反过来,这表明应在这些SSc患者中积极开展GER治疗,因为这可能会减缓肺功能的恶化。

相似文献

1
Esophageal involvement and pulmonary manifestations in systemic sclerosis.系统性硬化症中的食管受累及肺部表现
Arthritis Rheum. 2001 Aug;45(4):346-54. doi: 10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L.
2
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.硬皮病中的胃食管反流与肺纤维化:一项使用pH阻抗监测的研究
Am J Respir Crit Care Med. 2009 Mar 1;179(5):408-13. doi: 10.1164/rccm.200808-1359OC. Epub 2008 Dec 18.
3
Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis.系统性硬化症中食管功能障碍与肺功能损害的关联
Am J Gastroenterol. 1998 Mar;93(3):341-5. doi: 10.1111/j.1572-0241.1998.00341.x.
4
Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.胃食管因素与系统性硬化症用力肺活量恶化的相关性。
J Rheumatol. 2013 Jun;40(6):850-8. doi: 10.3899/jrheum.120705. Epub 2013 Apr 1.
5
Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.系统性硬化症患者的食管功能:36例患者运动功能和酸反流的前瞻性评估
Am J Gastroenterol. 1993 Jun;88(6):870-6.
6
Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.系统性硬化症患者上消化道测压:一项前瞻性研究。
Arthritis Rheum. 1998 Oct;41(10):1874-83. doi: 10.1002/1529-0131(199810)41:10<1874::AID-ART21>3.0.CO;2-T.
7
Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.合并和不合并间质性肺疾病的系统性硬化症中重度肺动脉高压的患病率及特征
J Rheumatol. 2007 May;34(5):1005-11. Epub 2007 Apr 15.
8
High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.大剂量泼尼松龙和冲击环磷酰胺治疗系统性硬化症相关间质性肺病:一项前瞻性开放研究。
Int J Rheum Dis. 2009 Sep;12(3):239-42. doi: 10.1111/j.1756-185X.2009.01417.x.
9
Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy.接受质子泵抑制剂治疗的系统性硬化症患者的食管黏膜受累情况。
Aliment Pharmacol Ther. 2006 Dec;24(11-12):1593-601. doi: 10.1111/j.1365-2036.2006.03180.x.
10
Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.胃食管反流引发系统性硬化症间质性肺病:临床、放射学、组织病理学和治疗证据。
Semin Arthritis Rheum. 2010 Dec;40(3):241-9. doi: 10.1016/j.semarthrit.2010.03.002. Epub 2010 May 21.

引用本文的文献

1
Systemic Sclerosis with Interstitial Lung Disease: Identification of Novel Immunogenetic Markers and Ethnic Specificity in Kazakh Patients.系统性硬化症合并间质性肺病:哈萨克族患者中新免疫遗传标志物的鉴定及种族特异性
Epidemiologia (Basel). 2025 Aug 6;6(3):41. doi: 10.3390/epidemiologia6030041.
2
Gastrointestinal Hemorrhage in CREST Syndrome: A Case Report.CREST综合征中的胃肠道出血:一例报告
Cureus. 2025 Jun 14;17(6):e85978. doi: 10.7759/cureus.85978. eCollection 2025 Jun.
3
Prevalence of Gastroesophageal Reflux in Interstitial Lung Diseases Clinic.
间质性肺病门诊中胃食管反流的患病率
Cureus. 2024 Dec 27;16(12):e76454. doi: 10.7759/cureus.76454. eCollection 2024 Dec.
4
Managing Symptoms of Systemic Sclerosis for the Allergist-Immunologist.变应原学家-免疫学家治疗系统性硬化症的症状
Curr Allergy Asthma Rep. 2024 Aug;24(8):433-441. doi: 10.1007/s11882-024-01155-9. Epub 2024 Jun 21.
5
Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan.日本系统性硬化症患者药物难治性反流性食管炎的患病率和危险因素。
J Gastroenterol. 2024 Mar;59(3):179-186. doi: 10.1007/s00535-024-02076-0. Epub 2024 Jan 22.
6
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease.质子泵抑制剂在系统性硬化症中的应用:优化胃食管反流病治疗的重新评估
Lancet Rheumatol. 2022 Nov;4(11):e795-e803. doi: 10.1016/S2665-9913(22)00183-7. Epub 2022 Jul 25.
7
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study.系统性硬化症患者食管运动障碍与肺部受累之间的关联:一项回顾性研究。
Rheumatol Int. 2024 Dec;44(12):2905-2910. doi: 10.1007/s00296-023-05399-y. Epub 2023 Aug 5.
8
Associations Between Patterns of Esophageal Dysmotility and Extra-Intestinal Features in Patients With Systemic Sclerosis.系统性硬化症患者食管动力障碍模式与肠外特征的相关性。
Arthritis Care Res (Hoboken). 2023 Aug;75(8):1715-1724. doi: 10.1002/acr.25080. Epub 2023 Feb 17.
9
Association of Symptoms of Gastroesophageal Reflux, Esophageal Dilation, and Progression of Systemic Sclerosis-Related Interstitial Lung Disease.胃食管反流症状、食管扩张与系统性硬化症相关间质性肺病进展的相关性。
Arthritis Care Res (Hoboken). 2023 Aug;75(8):1690-1697. doi: 10.1002/acr.25070. Epub 2023 Feb 7.
10
Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.观点:一种多学科方法评估系统性硬化症相关间质性肺疾病患者。
Clin Rheumatol. 2023 Mar;42(3):653-661. doi: 10.1007/s10067-022-06408-4. Epub 2022 Oct 21.